Видео ютуба по тегу Enzalutamide

Channel 10 News ANZUP Enzalutamide trial
Channel 10 News ANZUP Enzalutamide trial
Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
Comparing Apalutamide and Enzalutamide in Real-World Treatment of mCSPC
Comparing Apalutamide and Enzalutamide in Real-World Treatment of mCSPC
Enzalutamide monotherapy in hormone naive prostate cancer
Enzalutamide monotherapy in hormone naive prostate cancer
Azel 80 capsule uses and side effects in hindi?Enzalutamide 80 mg for prostate gland cancer |#cancer
Azel 80 capsule uses and side effects in hindi?Enzalutamide 80 mg for prostate gland cancer |#cancer
PRESIDE: investigating continued treatment with enzalutamide in PC following disease progression
PRESIDE: investigating continued treatment with enzalutamide in PC following disease progression
Dr. Maughan on Enzalutamide Plus Radium-223 in mCRPC
Dr. Maughan on Enzalutamide Plus Radium-223 in mCRPC
ARCHES trial overview: ADT plus enzalutamide for metastatic hormone-sensitive prostate cancer
ARCHES trial overview: ADT plus enzalutamide for metastatic hormone-sensitive prostate cancer
Dr. Grivas on Cabazitaxel/Enzalutamide in mCRPC
Dr. Grivas on Cabazitaxel/Enzalutamide in mCRPC
The PREVAIL Study: Primary and Non-Visceral Results for Enzalutamide
The PREVAIL Study: Primary and Non-Visceral Results for Enzalutamide
Enzalutamide | Jasgur Life Science | Enzabuzz #jasgurlifescience
Enzalutamide | Jasgur Life Science | Enzabuzz #jasgurlifescience
Dr. Charles Ryan Discusses Abiraterone and Enzalutamide for mCRPC
Dr. Charles Ryan Discusses Abiraterone and Enzalutamide for mCRPC
Zydus Lifesciences received approval from USFDA
Zydus Lifesciences received approval from USFDA
EMBARK: treatment suspension and health-related quality of life in prostate cancer
EMBARK: treatment suspension and health-related quality of life in prostate cancer
Early results of mevrometostat & enzalutamide in mCRPC at ASCO GU 2025
Early results of mevrometostat & enzalutamide in mCRPC at ASCO GU 2025
Enzalutamide in Men with Nonmetastatic, Castration resistant Prostate Cancer.
Enzalutamide in Men with Nonmetastatic, Castration resistant Prostate Cancer.
Dr. Kohli on the Use of Enzalutamide and Apalutamide in mHSPC
Dr. Kohli on the Use of Enzalutamide and Apalutamide in mHSPC
TALAPRO-2 Study of Talazoparib/Enzalutamide in Prostate Cancer: Stephen Freedland and Neeraj Agarwal
TALAPRO-2 Study of Talazoparib/Enzalutamide in Prostate Cancer: Stephen Freedland and Neeraj Agarwal
PCa Commentary - nmCRPC and Androgen Receptor Inhibition: Enzalutamide, Apalutamide and Darolutamide
PCa Commentary - nmCRPC and Androgen Receptor Inhibition: Enzalutamide, Apalutamide and Darolutamide
Talazoparib Plus Enzalutamide: TALAPRO-2 Results and Subset Analyses
Talazoparib Plus Enzalutamide: TALAPRO-2 Results and Subset Analyses